DERMATOMYOSITIS

Clinical trials for DERMATOMYOSITIS explained in plain language.

Never miss a new study

Get alerted when new DERMATOMYOSITIS trials appear

Sign up with your email to follow new studies for DERMATOMYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 17 Not yet recruiting 1 Not yet finished but already full! 7 Completed 7 Terminated 1

Dermatomyositis drug trial halted early – what we learned

Disease control Terminated

This study tested a weekly injection of Hizentra® (a concentrated antibody solution) in 134 adults with dermatomyositis, a rare disease causing muscle weakness and skin rash. The goal was to see if it could improve muscle and skin symptoms better than a placebo. The trial was sto…

Matched conditions: DERMATOMYOSITIS

Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control

Last updated May 11, 2026 20:37 UTC

DERMATOMYOSITIS

Get alerted when new DERMATOMYOSITIS trials appear

Dermatomyositis drug trial halted early – what we learned